Skip to main content

Teva Pharmaceutical Industries Ltd 10-Q for FY2025 Q1

Teva Pharmaceutical Industries Ltd (TEVA)

10-Q 2025-05-07 For: 2025-03-31
View Original
Added on April 03, 2026

About this 10-Q

Teva Pharmaceutical Industries Ltd filed this 10-Q on May 7, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).

Headline figures

Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3.89B
up 1.9% from $3.82B a year earlier
Net income
$214M
compared with a net loss of $139M a year earlier
Diluted EPS
$0.18
compared with -$0.12 a year earlier